CanSinoBIO

About:

Tianjin CanSino Biotechnology Inc. is a vaccine manufacturing facility.

Website: http://www.cansinotech.com/

Top Investors: Qiming Venture Partners, Bill & Melinda Gates Foundation, Lilly Asia Ventures, Gopher Asset Management, Fortune Capital

Description:

Tianjin CanSino Biotech Inc. is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices.

Total Funding Amount:

$289M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Tianjin, Guangdong, China

Founded Date:

2009-01-01

Contact Email:

info(AT)cansinotech.com

Founders:

Dongxu Qiu, Tao Zhu, Xuefeng Yu

Number of Employees:

101-250

Last Funding Date:

2023-10-25

IPO Status:

Public

Industries:

© 2025 bioDAO.ai